Sale!

Raloxifene

£16.23

-28%
Raloxifene is a medicine used to help lower the risk of breast cancer in people who are at higher risk. It can also treat and prevent osteoporosis in some post‑menopausal women by slowing bone loss. Raloxifene works by acting on oestrogen receptors. It is usually taken once a day. Common side effects include hot flushes and leg cramps. Seek urgent help for symptoms of a blood clot, such as sudden leg swelling or breathing difficulty.

Raloxifene (Raloxifene) – Patient-Friendly Guide (UK)

Raloxifene is a medicine used in specific hormone-related conditions, most notably to help prevent osteoporosis in postmenopausal women and to treat/ reduce risk of certain types of breast cancer in appropriate groups. This guide explains how it works, how it is taken, important safety information, and practical considerations for everyday use in the United Kingdom.

At a glance Details
Medicine name Raloxifene
Common uses Prevention/treatment of osteoporosis in postmenopausal women; reduction of risk of certain breast cancers
How it works A selective oestrogen receptor modulator (SERM)
Typical dosing (adults) Often 60 mg once daily (follow your own prescribed plan)
Key precautions Blood clot risk, stroke risk in some people, hot flushes, leg swelling; discuss risk factors
Food/alcohol Food usually does not significantly change effect; alcohol should be used cautiously
Where to get it (UK) Available through UK pharmacies; availability depends on stock and local supply

Basic product information

  • Generic name: Raloxifene
  • Drug class: Selective Oestrogen Receptor Modulator (SERM)
  • Who it’s for: Usually postmenopausal women
  • Forms: Tablets (strengths vary; commonly 60 mg)

Raloxifene is designed to act like oestrogen in some tissues (such as bone) while blocking oestrogen in others (such as breast tissue). This “tissue-selective” activity is central to its benefits and safety profile.

How raloxifene works (mechanism of action)

Raloxifene works by binding to oestrogen receptors. Depending on the tissue type, it behaves as: an oestrogen agonist (helping mimic oestrogen effects) or an oestrogen antagonist (blocking oestrogen effects).

  • Bone: Helps reduce bone breakdown and supports bone mineral density, lowering fracture risk.
  • Breast: Blocks oestrogen activity, which can help reduce risk of certain hormone-dependent breast changes.
  • Uterus: Generally does not stimulate the uterine lining in the same way oestrogen can, but abnormal uterine bleeding should still be reported promptly.
  • Blood vessels: Can affect clotting risk (see safety section).

Pharmacokinetics (how the body handles it)

Pharmacokinetics describes what happens to a medicine after you take it—absorption, distribution, metabolism, and elimination. While individual responses vary, the following points are important for understanding timing and consistency.

  • Absorption: Raloxifene is absorbed after oral dosing. Peak levels generally occur within hours.
  • Distribution: It binds to plasma proteins and is distributed throughout the body tissues.
  • Metabolism: It is metabolised primarily in the liver.
  • Elimination: It is cleared gradually, with an elimination half-life that supports once-daily dosing.

Because it has a sustained presence in the body, taking it at the same time each day can help you maintain steady levels, especially if you are using it long-term for bone health.

Typical uses in the UK

Raloxifene is used for specific indications. Your healthcare professional will consider your age, menopause status, fracture risk, and breast cancer history/risk before recommending it.

1) Osteoporosis in postmenopausal women

  • Prevention of osteoporosis in postmenopausal women at risk
  • Reduction of fracture risk in people who meet clinical criteria

2) Breast cancer risk reduction

  • Reduction in risk of invasive breast cancer in appropriate postmenopausal women
  • Often considered for hormone receptor–positive risk profiles

Important:

Raloxifene is not suitable for everyone. It is not a replacement for treatments aimed at established aggressive cancer, and it is not used to treat acute symptoms. If you have a current diagnosis or complex medical history, speak to a clinician promptly for personalised advice.

Dosing and timing (how to take it)

Dosing can vary depending on the condition being treated and your personal risk factors. Always follow the instructions provided with your medicine.

Common adult dosing

  • Often: 60 mg once daily
  • Route: By mouth

Timing tips

  • Try to take it at the same time each day to build a routine.
  • If you miss a dose, do not double up. Take the next dose at the usual time.
  • If you are switching medicines (for example from another osteoporosis therapy), ask your clinician or pharmacist about the safest transition.

When to seek advice urgently

Stop taking the medicine and seek urgent medical advice if you develop signs of a blood clot, such as:

  • Sudden shortness of breath
  • Coughing blood
  • Chest pain
  • One-sided leg swelling, pain, warmth, or redness

Food interactions and diet considerations

Raloxifene can generally be taken with or without food. Food is not typically a major factor in its effectiveness. However, practical habits matter:

  • Taking it with a glass of water and a normal meal pattern can help with tolerability.
  • If you experience stomach upset, taking it with food may be more comfortable.

Calcium and vitamin D: For osteoporosis, many people are advised to ensure adequate calcium and vitamin D intake (from diet and/or supplements). Your healthcare professional can advise what is appropriate for your situation and local guidance.

Alcohol interactions

Moderate alcohol intake is not usually described as a direct interaction that makes raloxifene unsafe. However, alcohol may indirectly affect bone health, increase fall risk, and worsen hot flushes or general side effects for some people.

  • Keep alcohol moderate and be mindful of balance, especially if you feel dizzy or unwell.
  • If you drink heavily, discuss with your clinician because it may influence liver function and overall risk profile.

Medicine interactions (important)

Many medicines can interact with raloxifene by changing how it is metabolised or by compounding side effects. Always tell your pharmacist or clinician about all medicines you take, including herbal products and over-the-counter drugs.

Common interaction themes

  • Liver-metabolised drugs: Medicines that strongly affect liver enzymes may alter raloxifene exposure.
  • Other hormone therapies: Avoid combining with unnecessary hormone treatments unless specifically advised.
  • Cholestyramine/ bile acid binding resins: These can reduce raloxifene absorption and effectiveness.
  • Warfarin or other anticoagulants: Special care is required if you are on blood-thinning medicines due to bleeding/thrombosis complexity.

Practical interaction checklist

  • Bring a list of your medicines to every review.
  • Check with your pharmacist before starting new prescriptions or herbal remedies.
  • Report unexpected changes such as unusual bruising, new swelling, or signs of clotting.

Safety profile and side effects

Like all medicines, raloxifene can cause side effects. Some side effects are mild and improve with time, while others are serious and require prompt action.

Common side effects

  • Hot flushes
  • Leg cramps or pain
  • Headache
  • Swelling in the legs/ankles (oedema)
  • Flu-like symptoms in some people

Serious risks (seek urgent medical advice)

The most important safety concern with raloxifene involves blood clot risk. It can increase the risk of:

  • Deep vein thrombosis (DVT)
  • Pulmonary embolism (PE)
  • Stroke risk in certain higher-risk groups

Risk may be higher if you have a personal/family history of clots, prolonged immobility, recent surgery, active cancer, or certain cardiovascular risk factors. Your clinician will assess your individual suitability.

Uterine symptoms

  • Any abnormal vaginal bleeding should be assessed promptly.
  • Report pelvic pain or unusual discharge to a clinician.

Who should take extra care

  • People with a history of blood clots or stroke
  • Those with significant cardiovascular risk
  • People who are immobile for long periods
  • Those who need major surgery soon (discuss a temporary plan ahead of time)

Practical use tips

1) Reduce clot risk in everyday life

  • Stay active where possible; avoid long periods of immobility.
  • During long journeys, stand up regularly and move your legs.
  • Stay hydrated and recognise early symptoms of DVT/PE.

2) Plan around surgery and hospital stays

If you are having surgery, prolonged hospitalisation, or extended immobilisation, ask your clinician about whether raloxifene should be temporarily paused and when to restart. Planning reduces risk.

3) Manage hot flushes

  • Dress in layers, keep the room cool, and use fan/air conditioning if available.
  • Limit triggers like spicy foods and overheating.
  • Discuss symptom severity with a healthcare professional; do not add new hormone treatments without advice.

4) Take adherence seriously

  • Use a daily reminder (phone alarm, pill organiser).
  • Keep the medicine in its original packaging to protect it and identify the strength.
  • If you miss doses often, speak to a pharmacist to troubleshoot barriers.

Alternative options (depending on your condition)

Alternatives depend on why you are taking raloxifene—bone health vs cancer risk reduction. Your clinician can guide you toward the most suitable option.

Bone health (osteoporosis) alternatives

  • Bisphosphonates (e.g., alendronate, risedronate, zoledronic acid)
  • Denosumab
  • Hormone therapy in select cases (risk/benefit assessment required)
  • Other bone agents as appropriate for your risk profile

Breast cancer risk reduction alternatives

  • Other SERMs (selection depends on your medical profile)
  • Other hormone-related risk strategies based on clinical assessment

When comparing options, consider side effect profiles, clot risk, fracture benefit, route of administration, and your other medical conditions.

Market and legal context in the UK

Raloxifene is an established medicine within the UK. Like other medicines, it is regulated under the Medicines and Healthcare products Regulatory Agency (MHRA) and must follow UK safety, quality, and labelling requirements.

National and professional guidance for osteoporosis and breast cancer prevention risk management may influence which patients are offered raloxifene. Medicines may also be reviewed over time as additional evidence emerges.

Recent UK guidance (high-level)

Guidance for osteoporosis prevention and management in postmenopausal women is updated periodically by bodies such as National Institute for Health and Care Excellence (NICE) and professional societies. For breast cancer risk reduction, eligibility and preferred strategies depend on risk factors and specialist assessment.

  • Osteoporosis: Ongoing focus on fracture risk assessment, lifestyle measures, adequate calcium/vitamin D, and appropriate use of bone-protective therapies.
  • Breast cancer risk: Emphasis on individual risk assessment and selecting the most benefit-favourable strategy.
  • Safety: Repeated reminders about thromboembolic risks and the importance of reporting symptoms promptly.

Your healthcare professional can confirm whether raloxifene remains an appropriate choice for your specific situation.

Delivery and availability (UK online pharmacy)

Availability can vary based on stock levels and local supply routes. When ordering online, your pharmacy typically aims to dispatch once the medicine is confirmed as in stock.

  • Delivery: Usually offered via standard and/or tracked options (delivery times depend on location and courier).
  • Cold chain: Raloxifene tablets generally do not require refrigeration.
  • Packaging: Medicines are shipped in secure packaging to protect tablets and provide correct labelling.
  • Out of stock: If a product is temporarily unavailable, the pharmacy may offer alternatives or restock notifications.

If you have an urgent need for your medicine, contact customer service so the pharmacy can advise on timing and options.

FAQ – Frequently asked questions

Is raloxifene the same as hormone replacement therapy (HRT)?

No. Raloxifene is a SERM that selectively affects different tissues. While it can help protect bone, it is not the same as standard HRT. Its tissue effects and safety considerations differ, especially regarding breast and clot risks.

How long does it take to work?

Bone benefits and risk reduction strategies are generally long-term. You may not notice immediate symptom changes, but the protective effect on bone metabolism and fracture risk typically develops over months. Continue as directed and attend scheduled reviews.

Can I take raloxifene with my other medicines?

Many medicines can be taken together, but interactions are possible. If you share your full list of medicines (including supplements and herbal products), your pharmacist can check for potential interactions and advise accordingly.

What should I do if I miss a dose?

Take the next dose at the usual time. Do not double the dose to make up for a missed tablet.

What side effects should I watch for most closely?

Seek urgent help if you have symptoms that could indicate a blood clot (e.g., sudden breathlessness, chest pain, or one-sided leg swelling). Report abnormal uterine bleeding or severe new symptoms promptly.

Does raloxifene cause weight gain?

Weight change is not typically considered a common direct effect of raloxifene. However, individual experiences vary and other factors (diet, activity, menopause-related changes) can influence weight.

Can I drink alcohol while taking raloxifene?

Moderate alcohol intake is generally not described as a direct interaction. Still, alcohol can worsen hot flushes and affect balance and bone health. If you have concerns (e.g., heavy drinking or liver conditions), speak to a pharmacist or clinician.

Can raloxifene be used in men?

Raloxifene is primarily used in postmenopausal women for the indications described above. Use in men depends on specific clinical circumstances and is not routine.

Is it safe to stop raloxifene if I feel fine?

Stopping may reduce the protective benefits for bone health and risk reduction. Decisions to stop should be discussed with a clinician, especially if you are taking it for fracture prevention.

Summary

Raloxifene is a SERM medicine used in the UK to support bone health and to help reduce risk of certain breast cancers in appropriate postmenopausal women. It works by acting like oestrogen in some tissues and blocking it in others. While it can offer important benefits, it also carries key safety considerations—particularly the risk of blood clots.

If you have questions about suitability, side effects, or interactions with your current medicines, consult a pharmacist for advice tailored to your health background.

Additional information

Dosage: No selection

60mg

Package: No selection

10 pill, 30 pill, 60 pill, 90 pill, 120 pill, 180 pill, 360 pill